
MLD-S2-M4: The Role of Microglia - The Latest Research and the Implications for Patients with MLD

Connecting Pediatricians to Improve Child Health GloballyThe Excellence in Pediatrics Community is a collaborative global network allowing members to engage in peer-to-peer learning through our online communication platform. The EIP Community enables members to connect and work with their colleagues around the world. Our members are the core of the EIP Institute deciding on priorities, and shaping our activities. The Excellence in Pediatrics Community is open for individual healthcare professionals from all over the world to become members and is free to join and participate in. |
||||
ACCESS OUR FREE RESOURCES |
||||
We are taking the learning outside the halls and arranging a series of free-to-view webinars, hosted and promoted every month throughout the year. EIP's target is to increase awareness and knowledge among frontline child healthcare professionals through Peer-to-Peer education and sharing essential information. Webinars are recorded and made available to the 45,000 healthcare professionals connected to EIP, and many thousands more around the world. Over the past years, EIP has developed extensive online educational content by recording sessions of the annual conference delivered by leading Key Opinion Leaders in Pediatrics. Our libraries of RECORDED WEBINARS, RECORDED CONFERENCE SESSIONS LIBRARY and our ACCREDITED COURSES allows you to update your skills and knowledge anywhere and at any time. |
||||
BE PART OF THE SPOT THE EARLY SIGNS EDUCATION PROGRAM |
||||
The program aims to fight under-diagnosed or late-diagnosed conditions for which treatments are available and where early detection and early treatment could make a significant difference in the condition's development, the quality of life and the survival of patients. Following a Peer-to-Peer educational approach, the program targets to improve everyday practice and the way child healthcare professionals advise and treat the children and families they support. Pediatricians and family doctors are likely to be the first healthcare professionals to observe symptoms, and it is important to help these front-line clinicians suspect, diagnose, and refer patients as early as possible. |
Presenters: Nicole I Wolf, Ass. Professor, Department of Child Neurology, Center for Childhood White Matter Diseases, Emma Children's Hospital, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, and Amsterdam Neuroscience, (Netherlands) ● Simon Jones, Consultant in Paediatric Inherited Metabolic Disease, Senior Lecturer, The University of Manchester (UK) ● Ingeborg Kraegeloh-Mann, Professor of Paediatrics, Managing Director University Children's Hospital, Medical Director Department of Paediatrics and Developmental Neurology, Eberhard Karls University Children Hospital Tübingen (Germany) ● Francesca Fumagalli, Neurologist, Pediatric Immunohematology Unit and Department of Neurology San Raffaele Hospital, Milan (Italy)